SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: BMcV who wrote (1411)11/11/1998 9:23:00 AM
From: billy d  Read Replies (1) | Respond to of 10280
 
Don't know about the experts on the thread, but the trading experts are bidding SEPR up pre-open; Bid 77 3/8 Ask 77 1/2.

This board sure is full of "visionaries". =)

Once again, congrats to all.



To: BMcV who wrote (1411)11/11/1998 2:16:00 PM
From: BDR  Read Replies (2) | Respond to of 10280
 
<<As I write, Joe Kernan on CNBC is saying "Sepracor, which has slowly--well not that slowly--crept up to over 70, announced good ph 2 results on one of their drugs.">>

Forgive me, but what is so good about the study? S-oxybutynin is better than placebo. I should hope so! At least it isn't worse. What I am waiting to see is the head to head comparison with Ditropan and Detrol.

Pardon my skepticism. (still long SEPR, but with a smaller position)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News